PL396080A1 - Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie - Google Patents

Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie

Info

Publication number
PL396080A1
PL396080A1 PL396080A PL39608011A PL396080A1 PL 396080 A1 PL396080 A1 PL 396080A1 PL 396080 A PL396080 A PL 396080A PL 39608011 A PL39608011 A PL 39608011A PL 396080 A1 PL396080 A1 PL 396080A1
Authority
PL
Poland
Prior art keywords
strain
bacteriophage
specific
culture
pcm
Prior art date
Application number
PL396080A
Other languages
English (en)
Other versions
PL217019B1 (pl
Inventor
Jaroslaw Dastych
Jarosław Dziadek
Elżbieta Fornal
Anna Rumijowska-Galewicz
Arkadiusz Wojtasik
Ewelina Wójcik
Original Assignee
Proteon Pharmaceuticals Spólka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteon Pharmaceuticals Spólka Akcyjna filed Critical Proteon Pharmaceuticals Spólka Akcyjna
Priority to PL396080A priority Critical patent/PL217019B1/pl
Priority to US14/240,195 priority patent/US9476086B2/en
Priority to PT12770231T priority patent/PT2747578T/pt
Priority to HUE12770231A priority patent/HUE041484T2/hu
Priority to PCT/IB2012/054070 priority patent/WO2013027146A1/en
Priority to EP12770231.4A priority patent/EP2747578B1/en
Priority to TR2018/19164T priority patent/TR201819164T4/tr
Priority to RU2014111125/10A priority patent/RU2573934C2/ru
Priority to ES12770231T priority patent/ES2710429T3/es
Priority to UAA201403018A priority patent/UA112551C2/uk
Publication of PL396080A1 publication Critical patent/PL396080A1/pl
Publication of PL217019B1 publication Critical patent/PL217019B1/pl
Priority to US15/297,587 priority patent/US9999237B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/00021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/00032Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

Sposób otrzymywania szczepu bakteriofaga specyficznego wobec wybranego szczepu bakterii, charakteryzuje się tym, że a) uzyskuje się kolekcję szczepów bakteriofagowych zawierającą szczep bakteriofaga specyficzny wobec wybranego szczepu bakterii, b) prowadzi się hodowlę wybranego szczepu bakterii na jałowym medium hodowlanym, c) próbki hodowli nanosi się na specjalną wielodołkową płytkę pomiarową, dodaje się zawiesiny badanego szczepu bakteriofaga w różnych stężeniach i inkubuje się w temperaturze około 37°C przez co najmniej 4 godziny, d) do próbek hodowli dodaje się rezaurynę i kontynuuje się inkubację bez dostępu światła w temperaturze około 37°C przez co najmniej 3 godziny, e) kontroluje się barwę lub fluorescencję hodowli i szczep bakteriofagowy zawarty w hodowli która zachowała barwę niebieską lub nie wykazała istotnego wzrostu fluorescencji w porównaniu z próbą kontrolną identyfikuje się jako szczep bakteriofaga specyficzny wobec wybranego szczepu bakterii, przy czym jako próbę kontrolną stosuje się jałową próbę poddaną takiej samej inkubacji, f) namnaża się zidentyfikowany szczep bakteriofaga specyficzny wobec wybranego szczepu bakterii. Przedmiotem zgłoszenia jest też zastosowanie bakteriofagów do wytwarzania preparatu do zapobiegania lub zwalczania zakażeń zwierząt hodowlanych, zwłaszcza drobiu, patogennymi szczepami bakterii wrażliwymi na działanie tych bakteriofagów, przy czym wytwarzany preparat jest przeznaczony do podawania zagrożonym zwierzętom wraz pokarmem lub wodą w odstępach od jednego do siedmiu dni. Zwalczanym zakażeniem jest zakażenie drobiu patogennymi szczepami Salmonella sp., a do wytwarzania preparatu stosuje się szczep bakteriofaga wybrany z grupy obejmującej: PCM F/00069 (szczep 8 sent 1748), PCM F/00070 (szczep 8 sent 65) oraz PCM F/00071 (szczep 3 sent 1).
PL396080A 2011-08-25 2011-08-25 Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie PL217019B1 (pl)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PL396080A PL217019B1 (pl) 2011-08-25 2011-08-25 Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie
EP12770231.4A EP2747578B1 (en) 2011-08-25 2012-08-09 The method of obtaining a strain of bacteriophage, specific strains of bacteriophage and use thereof
PT12770231T PT2747578T (pt) 2011-08-25 2012-08-09 O método para obter uma estirpe de bacteriófago, estirpes específicas de bacteriófago e sua utilização
HUE12770231A HUE041484T2 (hu) 2011-08-25 2012-08-09 Eljárás bakteriofág törzs elõállítására, specifikus bakteriofág törzsek és alkalmazásuk
PCT/IB2012/054070 WO2013027146A1 (en) 2011-08-25 2012-08-09 The method of obtaining a strain of bacteriofage, specific strains of bacteriophage and use thereof
US14/240,195 US9476086B2 (en) 2011-08-25 2012-08-09 Bacteriophage with activity against pathogenic strains of Salmonella
TR2018/19164T TR201819164T4 (tr) 2011-08-25 2012-08-09 Bi̇r bakteri̇yofaj suşu, spesi̇fi̇k bakteri̇yofaj suşlarinin elde edi̇lmesi̇ne yöneli̇k yöntem ve bunlarin kullanimi.
RU2014111125/10A RU2573934C2 (ru) 2011-08-25 2012-08-09 Способ получения штамма бактериофага, специфических штаммов бактериофагов и их применение
ES12770231T ES2710429T3 (es) 2011-08-25 2012-08-09 Método para obtener una cepa de bacteriófago, cepas específicas de bacteriófago y uso de las mismas
UAA201403018A UA112551C2 (uk) 2011-08-25 2012-09-08 Штам бактеріофага та його застосування
US15/297,587 US9999237B2 (en) 2011-08-25 2016-10-19 Method of inhibiting the growth of Salmonella

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL396080A PL217019B1 (pl) 2011-08-25 2011-08-25 Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie

Publications (2)

Publication Number Publication Date
PL396080A1 true PL396080A1 (pl) 2013-03-04
PL217019B1 PL217019B1 (pl) 2014-06-30

Family

ID=47010653

Family Applications (1)

Application Number Title Priority Date Filing Date
PL396080A PL217019B1 (pl) 2011-08-25 2011-08-25 Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie

Country Status (10)

Country Link
US (2) US9476086B2 (pl)
EP (1) EP2747578B1 (pl)
ES (1) ES2710429T3 (pl)
HU (1) HUE041484T2 (pl)
PL (1) PL217019B1 (pl)
PT (1) PT2747578T (pl)
RU (1) RU2573934C2 (pl)
TR (1) TR201819164T4 (pl)
UA (1) UA112551C2 (pl)
WO (1) WO2013027146A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL231923B1 (pl) * 2013-10-28 2019-04-30 Proteon Pharmaceuticals Spolka Akcyjna Sposób enkapsulacji materiału zawierającego bakteriofagi, otrzymywana nim mikrokapsułka oraz jej zastosowania
WO2017089947A2 (es) 2015-11-25 2017-06-01 Universidad De Los Andes Composición que comprende bacteriófagos para reducir, eliminar y/o prevenir salmonella enteritidis, salmonella typhimurium y salmonella paratyphi b
ITUA20162204A1 (it) * 2016-04-08 2017-10-08 Cosvitec Soc Cons A R L Protocollo di isolamento ed utilizzo di batteriofagi, tal quali ed in combinazione con lattoferrina, per la produzione di presidi per la conservazione degli alimenti, la sanificazione degli ambienti e la cura di sindromi gastroenteriche da salmonella spp. in uomo ed animali
US20190316169A1 (en) * 2016-11-28 2019-10-17 Sonanutech Inc. Methods, compositions, and kits for detecting a cell in a sample
WO2019040881A1 (en) * 2017-08-25 2019-02-28 The United State Of America As Represented By The Secretary Of The Navy METHODS OF IDENTIFYING BACTERIOPHAGES THAT CAN INFECT AND KILL INFECTIOUS PATHOGENIC BACTERIA SUITABLE FOR HOST
CN108179197B (zh) * 2018-01-09 2021-11-30 山东农业大学 鸡环RNA Chr9:10814512|10838667基因检测引物、方法及应用
FR3103198B1 (fr) 2019-11-15 2024-07-26 Commissariat Energie Atomique Procédé de détermination de la sensibilité d'une souche bactérienne à l'égard d'un virus bactériophage.
CN112725289A (zh) * 2021-01-25 2021-04-30 南京悦联生物科技有限公司 一种快速筛选治疗用噬菌体的方法
WO2024204716A1 (ja) * 2023-03-31 2024-10-03 株式会社カネカ バクテリオファージ、サルモネラ属細菌溶菌剤、組成物、及びサルモネラ属細菌の防除方法
WO2024204717A1 (ja) 2023-03-31 2024-10-03 株式会社カネカ バクテリオファージ、サルモネラ属細菌溶菌剤、組成物、及びサルモネラ属細菌の防除方法
WO2024204715A1 (ja) 2023-03-31 2024-10-03 株式会社カネカ バクテリオファージ、組成物、及びサルモネラ属細菌の防除方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU543260A1 (ru) 1975-07-25 1984-04-15 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Противочумный Институт "Микроб" Способ получени холерных бактериофагов дл дифференциации вибрионов Эль-Тор на вирулентные и авирулентные
DE19517940A1 (de) 1995-05-18 1996-11-21 Merck Patent Gmbh Nachweis von Listerien mittels rekombinanter Bakteriophagen
EP1206566A4 (en) 1999-06-25 2002-07-17 Spring Diagnosting Ltd BACTERIOPHAGE BANK USEFUL IN THE TYPE OF BACTERIA AND SYSTEM AND METHOD BASED ON THE USE OF THE SAME
EP1458856B1 (en) * 2001-12-13 2012-06-13 Societe Des Produits Nestle S.A. Isolated phages and their use in food or pet food products
AU2003240505A1 (en) * 2002-06-05 2003-12-22 Iowa State University Research Foundation, Inc. Bacteriophage and enzymes lytic to salmonellae
RU2412243C1 (ru) * 2009-06-16 2011-02-20 Федеральное государственное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ГНЦ ВБ "Вектор" Роспотребнадзора) Штамм бактериофага salmonella typhimurium s-394, обладающий литической активностью
WO2011028061A2 (en) * 2009-09-03 2011-03-10 Cj Cheiljedang Corporation Novel bacteriophage and antibacterial composition comprising the same
US8329442B2 (en) 2009-09-03 2012-12-11 Cj Cheiljedang Corporation Salmonella bacteriophage and antibacterial composition comprising the same

Also Published As

Publication number Publication date
HUE041484T2 (hu) 2019-05-28
PL217019B1 (pl) 2014-06-30
UA112551C2 (uk) 2016-09-26
US9476086B2 (en) 2016-10-25
TR201819164T4 (tr) 2019-03-21
US9999237B2 (en) 2018-06-19
RU2014111125A (ru) 2015-09-27
US20140220659A1 (en) 2014-08-07
EP2747578B1 (en) 2018-09-12
EP2747578A1 (en) 2014-07-02
WO2013027146A1 (en) 2013-02-28
RU2573934C2 (ru) 2016-01-27
US20170035077A1 (en) 2017-02-09
ES2710429T3 (es) 2019-04-25
PT2747578T (pt) 2019-01-21

Similar Documents

Publication Publication Date Title
PL396080A1 (pl) Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie
BR112014031658A2 (pt) método mixotrófico de aquicultura
Ingle et al. Biofilm formation by and thermal niche and virulence characteristics of Escherichia spp
Maes et al. Pseudomonas putida as a potential biocontrol agent against Salmonella Java biofilm formation in the drinking water system of broiler houses
Yamazaki et al. Campylobacter and Salmonella are prevalent in broiler farms in Kyushu, Japan: results of a 2‐year distribution and circulation dynamics audit
Vaz et al. Survey of pathogens in threatened wild red-tailed Amazon parrot (Amazona brasiliensis) nestlings in Rasa Island, Brazil
Hayakijkosol et al. Case report of bacterial infections in a redclaw crayfish (Cherax quadricarinatus) hatchery
Phung et al. Campylobacter hepaticus, the cause of spotty liver disease in chickens, can enter a viable but nonculturable state
Cain et al. Laboratory maintenance of Flavobacterium psychrophilum and Flavobacterium columnare
Owoseni et al. Antimicrobial resistance and virulence genes profiling of Proteus species from poultry farms in Lafia, Nigeria
Kiess et al. Evaluation of different selective media and culturing techniques for the quantification of Campylobacter ssp. from broiler litter
Trotereau et al. Use of a chicken embryo lethality assay to assess the efficacy of phage therapy
Munang’andu et al. Bacteria isolations from broiler and layer chicks in Zambia
CN104304251B (zh) 一种吡咯类化合物用于制备农用杀菌剂的用途
Nuttall et al. Vibrio cyclitrophicus population‐specific biofilm formation and epibiotic growth on marine copepods
Inman III et al. The effects of trehalose on the bioluminescence and pigmentation of the phase I variant of Photorhabdus luminescens
Hughes Coculture of Probiotic Bacteria in Algal Feedstocks for Disease Management in Bivalve Hatcheries
Claudia Assessment of antibiotic sensitivity patterns of Salmonella Typhimurium, Pseudomonas Aeru'ginosa, Klebsiella Pneumoniae Isolates from Barn Swallow Droppings in Ishaka Town, Bushenyi District, Uganda.
Rajawat et al. Impact of Environmental Factors on Clostridium perfringens Sporulation Isolated from Poultry Droppings-Contaminated Soils in the of Poultry Farms
Ahmed et al. Effect of some antiseptic and disinfectant on hemolysin production from clinical isolates of Serratia marcescens.
Zainuddin et al. Isolation and Characterization of Gut-derived Probiotic Bacteria from Clarias batrachus with Antagonistic Activity against Aquaculture Pathogens
Agnihotri MASTER OF VETERINARY SCIENCE
UA129687U (uk) Спосіб визначення антибактеріальної активності меду по відношенню до klebsiella pneumoniae
Jang et al. Comparison of different combinations of filters and DNA extraction method for quantitative airborne bacteria analysis
UA120725C2 (uk) Спосіб визначення антибактеріальної активності меду відносно klebsiella pneumoniae